I have no idea Ray but that's been the M.O. for years. Perhaps it was an attempt to get a short term pop on the pps for some to sell...but for those that are still holding shares...who would sell at anything below a dime...I suspect some are just quietly riding it out like me letting the chips fall where they may. Such a shame...this company has great products and the GBS studies should have sent sales upward; but it's difficult to get KOL's to look at new products...thought UTHSC would have inroads here and that the journal papers would provide the foundation for marketing. However, IMO there never was a "crack" marketing "team"...just one person, perhaps a Dr., and the CEO trying to do it all. I can fully understand and appreciate wanting to keep overhead low, expenses at a minimum, not do toxic financing or a R/S, and you can have the best product/s in the world but if you don't have the means to get it to market it you fail the BOD, PIPEs, shareholders, Advisers, other investors and most of all the company itself. I really hope the pending update isn't just a ploy and that we finally get some really great news, and as I said before, a partner that can successfully bring the products to market.